Norgestimate And Ethinyl Estradiol
Product Images NDC 53002-1732

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Norgestimate And Ethinyl Estradiol (NDC 53002-1732). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem Structures

Chemical structure diagrams of the active ingredients Norgestimate, USP and Ethinyl Estradiol, USP, showing their molecular arrangements as part of the product Norgestimate and Ethinyl Estradiol by RPK Pharmaceuticals, Inc.*

FDA Label Image

Fig C

An instructional diagram labeled Figure C showing a thumb pressing down on a circular pill within a blister pack. The image includes labels for days of the week 'SUN' and 'MON' and arrows indicating 'Start' and 'Week 2' directions for taking medication.*

FDA Label Image

Fig D

Illustration of two medication blister packs for Norgestimate and Ethinyl Estradiol tablets, showing a hand peeling back a protective layer. The packs display a 4-week layout with days of the week marked above the tablets. Dosages 0.25 mg/0.035 mg and a range including 0.18 to 0.25 mg/0.035 mg are noted. Warnings about child safety and medication storage are printed below each pack.*

FDA Label Image

Fig E

An instructional illustration labeled "Figure E" showing a finger pointing to the starting pill in a blister pack calendar for Norgestimate and Ethinyl Estradiol. Days of the week (Tuesday and Wednesday) are partially visible at the top, with arrows indicating the start and Week 2 positions.*

FDA Label Image

Fig F

An instructional diagram illustrating a weekly pill-taking schedule for Norgestimate and Ethinyl Estradiol. It shows circles organized by weeks and days (Sunday and Monday), with an arrow pointing to indicate the start of each week. A hand is depicted peeling a pill from a blister pack in the Week 4 Sunday position, demonstrating how to remove the pill.*

FDA Label Image

Img1 1

An illustrated medication schedule for Norgestimate and Ethinyl Estradiol Tablets USP 0.25 mg/0.035 mg showing a 28-day regimen. It includes four weekly rows of circles representing pill doses, labeled to distinguish active blue pills and inactive light green pills. Arrows indicate the start of weeks one, three, and four.*

FDA Label Image

Img1

An illustrated weekly pill schedule chart for Norgestimate and Ethinyl Estradiol Tablets USP 0.25 mg/0.035 mg. The chart outlines days by week (Weeks 1 to 4) with circles representing pills arranged in rows. Arrows indicate the start of each week, and a legend marks blue pills as active and light green pills as inactive. A caution note about child safety and medication handling appears at the bottom.*

FDA Label Image

Img2 1

Diagram of Norgestimate and Ethinyl Estradiol Tablets USP showing a 28-day pill pack layout organized by day of the week and week number, with color-coded pills: white to off-white, light blue, and blue pills are active; light green pills are inactive. The diagram also includes a note about child safety.*

FDA Label Image

Img2

An instructional diagram for Norgestimate and Ethinyl Estradiol Tablets USP showing a 28-day pill regimen with four weekly rows. Each week contains seven circles labeled by day (Sunday to Saturday). Color-coded pills are indicated: white to off-white (active), light blue (active), blue (active), and light green (inactive). The diagram includes a note about child safety.*

FDA Label Image

Img3

An effectiveness diagram for contraceptive methods showing pregnancy rates per 100 women in one year. It ranks options from fewer to more pregnancies, listing implants, injections, intrauterine devices, and sterilization as most effective; followed by birth control pills, skin patch, vaginal ring with hormones; condoms and diaphragm; no sex during fertile days, spermicide, withdrawal; and no birth control as least effective.*

FDA Label Image

Label Image (Lbl530021732)

Norgestimate and Ethinyl Estradiol Tablets 28-Day label from RPK Pharmaceuticals, Inc. The label indicates a package of 28 tablets to be taken once daily as directed in a 28-day regimen. It includes dosage instructions, pharmacy and patient information spaces, and barcode. The label specifies the active ingredients norgestimate and ethinyl estradiol and indicates Rx only.*

FDA Label Image

Logo 1

FDA Label Image

Logo

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.